Furthermore, comparison of the SUVs sixty minutes post injection showed that the human tumors positive for HLA-A2 and HER2/neu had statistically significant uptake and retention of 64Cu-DOTA-fE75 compared to the negative control tumor SKOV3 (paired t test, p<0.03, n = 4). This evidence concerns the gene ERBB2 and neoplasm.